238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
7.46%
Revenue growth of 7.46% while BIDU is flat. Bruce Berkowitz would check if a small edge can widen further.
11.19%
Gross profit growth of 11.19% while BIDU is zero. Bruce Berkowitz would see if minimal improvements could expand further.
240.74%
EBIT growth of 240.74% while BIDU is zero. Bruce Berkowitz would see if small gains can be scaled further.
240.74%
Operating income growth of 240.74% while BIDU is zero. Bruce Berkowitz would see if this modest edge can become significant.
23.59%
Net income growth of 23.59% while BIDU is zero. Bruce Berkowitz would see if small gains can accelerate into a larger gap.
176.60%
EPS growth of 176.60% while BIDU is zero. Bruce Berkowitz would see if minimal gains can accelerate over time.
182.61%
Diluted EPS growth of 182.61% while BIDU is zero. Bruce Berkowitz would see if minimal gains can be scaled further for a bigger lead.
-20.54%
Share reduction while BIDU is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-21.88%
Reduced diluted shares while BIDU is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-21.63%
Negative OCF growth while BIDU is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-43.70%
Negative FCF growth while BIDU is at 0.00%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
615.50%
10Y revenue/share CAGR above 1.5x BIDU's 167.42%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
615.50%
5Y revenue/share CAGR above 1.5x BIDU's 167.42%. David Dodd would look for consistent product or market expansions fueling outperformance.
615.50%
3Y revenue/share CAGR above 1.5x BIDU's 167.42%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
275.43%
Net income/share CAGR 1.25-1.5x BIDU's 225.10%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
275.43%
5Y net income/share CAGR 1.25-1.5x BIDU's 225.10%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
275.43%
3Y net income/share CAGR 1.25-1.5x BIDU's 225.10%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
31.24%
AR growth of 31.24% while BIDU is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
No Data
No Data available this quarter, please select a different quarter.
23.08%
Asset growth of 23.08% while BIDU is zero. Bruce Berkowitz checks if modest expansions can create a longer-term lead.
72.72%
BV/share growth of 72.72% while BIDU is zero. Bruce Berkowitz sees if small growth can compound into a strong advantage.
-15.86%
We’re deleveraging while BIDU stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
30.68%
R&D growth of 30.68% while BIDU is zero. Bruce Berkowitz checks if the moderate investment leads to meaningful product differentiation.
No Data
No Data available this quarter, please select a different quarter.